Introduction
The enhanced expression of delta opioid receptors (DORs) prepares activated mature peripheral T-cells for the immunomodulatory effects of exogenous and endogenous opioids. A relatively small fraction of naïve quiescent peripheral T-cells express DORs (Miller, 1996; Sharp et al., 2001; Sharp et al., 2005) . However, activation through the Tcell receptor (TCR) markedly up-regulates both the fraction of T-cells that express DORs and the number of DORs present on each T-cell. These findings are based on studies showing that DORs were induced in vivo by antigenic stimulation with staphyloccocal enterotoxin B (SEB) and in vitro by mitogen treatment or crosslinking the TCR (Miller, 1996; Shahabi et al. 2000; Sharp et al., 2001 ).
DOR agonists exert diverse immunomodulatory effects on T-cell responses including T-
cell proliferation, cytokine production, chemotaxis, and thymic T-cell selection (Shahabi and Sharp, 1995; Rogers et al., 2000; McCarthy et al., 2004) . Recent studies indicate that
DOR agonists affect intracellular signaling pathways in T-cells involving mitogen activated protein kinases (MAPK). For example, DADLE ([D-Ala 2 -D-Leu 5 ]-enkephalin),
a selective DOR agonist, rapidly and dose-dependently attenuated the anti-CD3-ε-induced phosphorylation of ERKs 1, 2 (Shahabi et al., 2000) . In contrast, DADLE alone was sufficient to stimulate the hyperphosphorylation of ATF-2 (activating transcription factor-2), which is involved in cytokine gene transcription (Shahabi et al., 2003) . 6 JNK suggest that activation of DOR may be sufficient to signal through certain intracellular pathways. Thus, we hypothesized that DADLE might stimulate c-jun phosphorylation in T-cells.
JNK is known to phosphorylate transcription factors and an array of other molecules known to regulate cell viability, cellular stress responses, apoptosis, and proliferation (for review, Manning and Davis, 2003) . c-Jun is one of multiple transcriptional proteins (e.g., ATF-2 and Nuclear Factor of Activated T-cell or NFAT) implicated in JNK signaling within T-cells. In addition to c-jun, JNK phosphorylates other transcription proteins that form activator protein-1 (AP-1) dimers (Hibi et al., 1993; Kallunki et al., 1996) .
Phosphorylation of the c-jun NH 2 -terminal activation domain enhances the activity of AP-1, promoting the transcription of T-cell cytokine genes such as interleukin-2 (IL-2), granulocyte-macrophage colony stimulating factor (GM-CSF; Thomas et al., 1997), gamma-interferon (IFN-gamma; Ye et al., 1996) , and tumor necrosis factor-alpha (TNFalpha; Becker et al., 1999) .
Recent studies of opioid receptor signaling in transfected COS-7, SH-SY5Y, and NG108-15 cell lines showed that opioid receptors activate JNK, as indicated by the detection of phosphorylated JNK and the transient phosphorylation of c-jun, using in vitro kinase assays (Kam et al., 2003; Kam et al., 2004) . Activation of JNK by the µ opioid receptor was dependent on phosphoinositide 3-kinase (PI3K), whereas DOR and κ opioid receptor signaling were not. In addition, Akt, a serine-threonine kinase that is one of the key downstream targets of PI3K (Cantrell, 2001) , was not implicated in JNK phosphorylation JPET #91447 7 by opioid receptors in these neuronal cell lines. However, both PI3K and Akt have been shown to facilitate agonist-induced mu opioid receptor desensitization in sensory neurons (Tan et al., 2003) . Thus, we determined whether DADLE induced the PI3K and Aktdependent phosphorylation of c-jun in splenic T-cells. We report herein that DADLEinduced JNK-dependent c-jun phosphorylation in normal T-cells, requiring both PI3K and Akt. Balb/c mice 5-7 weeks old were obtained from NCI (Bethesda, MD) and maintained for one week in specific pathogen-free facilities (12 h light/12 h dark) at a constant temperature (20°C) with ad libitum access to food and water. They were sacrificed by cervical dislocation under isofluorane anesthesia. All procedures were conducted in accordance with NIH guidelines and approved by the Animal Care Committee of the University of Tennessee. Spleens were dispersed through a wire mesh screen, erythrocytes were eliminated with lysing buffer, and then cells were spun, washed, and layered on Ficoll-Hypaque, followed by centrifugation at 400xg for 10 min. The interface layer was recovered, washed, and cultured at 2x10 6 cells/ml in RPMI-1640 with penicillin-streptomycin-glutamine, 5% (FBS), and 5x10 Membrane preparation:
Methods and Materials
Cells were washed briefly with PBS, lysed using 500 ml of RIPA buffer (1x PBS, 1%
Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 1mM sodium orthovanadate, and a mixture of protease and phosphatase inhibitors), and then sonicated 3 times (2-3 sec each) on ice. Lysates were centrifuged at 120,000xg for 60 min at 4°C. Pellets were This article has not been copyedited and formatted. The final version may differ from this version. 
Results
The initial set of experiments sought to determine whether DADLE, a specific DOR agonist, induced phosphorylation of c-jun in T-cells through DORs coupled to Gi proteins. In order to obtain data from normal lymphocytes, primary murine splenocyte cultures were utilized to minimize variation in responses. Since these cells transfect poorly, pharmacological rather than molecular approaches were taken in these studies. Naltrindole, a specific DOR antagonist, abolished the induction of phospho-c-jun by DADLE ( fig. 3 ), whereas naltrindole alone had no effect. Since neuronal DORs are known to signal through Gi-proteins, which are inhibited by pertussis toxin (PTX), the effect of this agent on DADLE-induced phosphorylation of c-jun was studied. Figure 4 demonstrates that pertussis toxin (100 ng/ml) also abolished the phosphorylation of c-jun by DADLE. Thus, DADLE dose-dependently induced the phosphorylation of c-jun in Tcells through DORs coupled to pertussis toxin-sensitive G-proteins.
The compound SP600125 (S) is a potent, specific inhibitor of the c-jun NH 2 -terminal kinases (JNK), which mediate phosphorylation of c-jun (Hibi et al., 1993; Bennett et al., 2001 ). Thus, this agent was used to demonstrate that DADLE-induced c-jun phosphorylation is dependent on JNK. Figure 5 shows that S alone had a small effect on the level of phospho-c-jun, and it largely prevented DADLE-induced phosphorylation.
Densitometric analysis confirmed this, demonstrating that DADLE (D6) significantly increased phospho-c-jun and S + D6 was significantly less (F = 6.67, p = 0.001; D6 vs. control, p < 0.001; D6 vs. S10 + D6, p = 0.001; D6 vs. S30 + D6, p = 0.01). 
Discussion
These investigations demonstrate that DORs stimulate phosphorylation of c-jun in splenic T-cells, and that this depends, as expected, on JNK. Although a prior report showed that DORs can enhance JNK activity in a neuronal cell line, this was independent of PI3K (Kam et al., 2003) . In contrast, we observed that PI3K was required for DADLE-induced c-jun phosphorylation in T-cells. As such, Akt, a proxy for PI3K activity, was phosphorylated by DADLE, and both wortmannin and LY294002 blocked c-jun however, its precise mechanism of action is unknown. And, in general, the specificity of Akt inhibitors has not been studied definitively. This second generation inhibitor was effective at lower concentrations than the first generation compound. Thus, in addition to PI3K, Akt appears to be required for DOR activation of JNK and c-jun.
Although opioid receptors activate JNK and c-jun, the potential role of Akt in signaling Dong et al., 1998) ; JNK-2 was necessary for Th1 differentiation (Yang et al., 1998) . In addition, JNK-2 may be involved in proliferation and differentiation of peripheral T-cells (Dong et al., 1998; Sabapathy et al., 1999) . Thus, both JNK-1 and -2 appear to be involved in the T helper cell type-specific differentiation.
Recent investigations indicate that N-terminal phosphorylation of c-jun by JNK is not required for T-cell proliferation and differentiation (Behrens et al., 2001 ). However,
JNK-2 is required in these processes, implicating another nuclear effector(s). JNK-2 has
This article has not been copyedited and formatted. The final version may differ from this version. 
